Long-term sirolimus in verrucous venous malformation cohort study and ponatinib as a potential therapeutic strategy for MAP3K3-mutatant-patient in vitro
收藏Mendeley Data2026-04-09 收录
官方服务：
资源简介：
"Long-term sirolimus in verrucous venous malformation cohort study and ponatinib as a potential therapeutic strategy for MAP3K3-mutatant-patient in vitro" Supplemental Data for JAAD Brief Report.
